245 related articles for article (PubMed ID: 8866625)
1. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
[TBL] [Abstract][Full Text] [Related]
3. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
Chiang LL; Yu CT; Kuo HP
Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
[TBL] [Abstract][Full Text] [Related]
4. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
[TBL] [Abstract][Full Text] [Related]
6. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
[TBL] [Abstract][Full Text] [Related]
7. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
[TBL] [Abstract][Full Text] [Related]
8. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of inhaled selective and non-selective adrenergic agonists on cardiorespiratory parameters in chronic stable asthma.
Williams AJ; Weiner C; Reiff D; Swenson ER; Fuller RW; Hughes JM
Pulm Pharmacol; 1994 Aug; 7(4):235-41. PubMed ID: 7620239
[TBL] [Abstract][Full Text] [Related]
11. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Bremner P; Siebers R; Crane J; Beasley R; Burgess C
Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
[TBL] [Abstract][Full Text] [Related]
12. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers.
Sandsund M; Sue-Chu M; Helgerud J; Reinertsen RE; Bjermer L
Eur J Appl Physiol Occup Physiol; 1998 Mar; 77(4):297-304. PubMed ID: 9562357
[TBL] [Abstract][Full Text] [Related]
13. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
Heir T; Stemshaug H
Scand J Med Sci Sports; 1995 Aug; 5(4):231-6. PubMed ID: 7552768
[TBL] [Abstract][Full Text] [Related]
14. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Scheinin M; Koulu M; Laurikainen E; Allonen H
Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
Hall IP; Woodhead MA; Johnston ID
Respiration; 1994; 61(4):214-8. PubMed ID: 7973107
[TBL] [Abstract][Full Text] [Related]
16. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
Malerba M; Boni E; Romagnoni G; Filippi B; Politi A; Giustina A; Tantucci C; Grassi V
Monaldi Arch Chest Dis; 1994 Dec; 49(5):389-93. PubMed ID: 7841973
[TBL] [Abstract][Full Text] [Related]
18. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD.
Viegas CA; Ferrer A; Montserrat JM; Barberà JA; Roca J; Rodriguez-Roisin R
Chest; 1996 Jul; 110(1):71-7. PubMed ID: 8681669
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
20. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
Bennett JA; Tattersfield AE
Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
